From April 8 to 11, 2025, Shenzhen Narigmed Biotech Co., Ltd. made a successful appearance at the 91st China International Medical Equipment Fair (CMEF 2025), held at the National Exhibition and Convention Center in Shanghai. As one of the most influential medical trade platforms in the Asia-Pacific region, this year’s CMEF brought together over 5,000 companies from more than 150 countries and regions, attracting over 310,000 professional visitors to explore the latest medical innovations and industry developments.
At the event, Narigmed unveiled its full range of vital signs monitoring solutions, including the latest generation of handheld pulse oximeters, neonatal and adult SpO₂ sensors, non-invasive blood pressure monitors, and newly developed smart wearable devices. These offerings are designed for both clinical and home health applications, featuring high-precision sensors and intelligent algorithms for real-time monitoring, ease of use, and enhanced patient comfort.
A key highlight this year was Narigmed’s expansion into the animal healthcare sector, with the debut of its innovative pet blood pressure monitor. Specifically designed for small animals such as dogs and cats, the device features flexible cuffs and sensitive probes tailored to different body types, balancing measurement accuracy with pet comfort. The product drew strong interest from veterinary clinics and pet health distributors, who praised Narigmed’s forward-thinking approach and technical expertise in bridging human and animal medical care.
【https://www.narigmed.com/nomk-01-spo2-parameter-module-product/】
Narigmed’s booth attracted a constant flow of visitors, including hospital procurement teams, international distributors, and medical professionals. Particularly well-received was Narigmed’s newly upgraded multi-parameter monitoring series, appreciated for its compact form factor, durability, and intuitive user interface.
Many loyal partners and new prospects provided highly positive feedback at the booth:
“Narigmed’s SpO₂ sensors are extremely reliable—among the most trustworthy we’ve used in practice.” — Distributor from Southeast Asia
“The user-centric design and responsive technical support make Narigmed an outstanding long-term partner.” — Procurement Manager from a European hospital group
The exhibition not only highlighted Narigmed’s strengths in vital signs monitoring technology but also opened new doors for global collaboration and international market expansion. Throughout the event, Narigmed’s team engaged in productive discussions with partners from Europe, South America, the Middle East, and Southeast Asia, laying a solid foundation for future cooperation.
Looking ahead, Narigmed remains committed to accelerating its internationalization strategy through:
-
Fast-tracking global product certifications to meet diverse market standards;
-
Establishing localized customer support and training systems;
-
Increasing R&D investment to enhance remote and continuous monitoring solutions;
-
Exploring AI integration for predictive analytics and early warning sysems;
-
Expanding its human-animal healthcare product ecosystem and exploring new opportunities in the global veterinary market.
“CMEF is not just a platform to showcase our products—it’s where we share our vision for the future of healthcare: smarter, more connected, and accessible to all,” said a representative from Narigmed’s International Business Department.
Narigmed extends heartfelt thanks to all partners, clients, and friends who visited us in Shanghai. We look forward to continued innovation and collaboration, delivering high-quality medical solutions that serve both people and animals worldwide.
For more product information and partnership opportunities, please visit: www.narigmed.com
Post time: Apr-19-2025
